149 related articles for article (PubMed ID: 38589341)
1. Epidemiology of cervical cancer and HPV infection in Asia and Oceania.
Ueda Y
J Obstet Gynaecol Res; 2024 Apr; ():. PubMed ID: 38589341
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
[TBL] [Abstract][Full Text] [Related]
3. A questionnaire study on disparity of cervical cancer prevention programs in Asia-Oceania.
; Tse KY; Ushijima K; Tan AL; Intasorn P; Pariyar J; Chang CL; Domingo EJ; Konar H; Kumarasamy S; Tjokroprawiro BA; Wilailak S
J Obstet Gynaecol Res; 2023 Apr; 49(4):1230-1243. PubMed ID: 36726190
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
5. Reducing HPV-associated cancer globally.
Lowy DR; Schiller JT
Cancer Prev Res (Phila); 2012 Jan; 5(1):18-23. PubMed ID: 22219162
[TBL] [Abstract][Full Text] [Related]
6. Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.
Bray F; Lortet-Tieulent J; Znaor A; Brotons M; Poljak M; Arbyn M
Vaccine; 2013 Dec; 31 Suppl 7():H32-45. PubMed ID: 24332296
[TBL] [Abstract][Full Text] [Related]
7. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.
Singh D; Vignat J; Lorenzoni V; Eslahi M; Ginsburg O; Lauby-Secretan B; Arbyn M; Basu P; Bray F; Vaccarella S
Lancet Glob Health; 2023 Feb; 11(2):e197-e206. PubMed ID: 36528031
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
9. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
10. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
11. News, views, trends: a world-wide survey of recent developments, fresh ideas and production plans.
World Tob; 1976 Oct; (54):43-54. PubMed ID: 12279414
[TBL] [Abstract][Full Text] [Related]
12. Awareness of human papillomavirus infection among Indigenous males in North America and Oceania: a Scoping Review.
Bedi S; Strachan R; Zehbe I
Cancer Causes Control; 2024 Mar; 35(3):437-449. PubMed ID: 37831275
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.
Smith JS; Lindsay L; Hoots B; Keys J; Franceschi S; Winer R; Clifford GM
Int J Cancer; 2007 Aug; 121(3):621-32. PubMed ID: 17405118
[TBL] [Abstract][Full Text] [Related]
14. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
15. The age structure of selected countries in the ESCAP region.
Hong S
Popul Res Leads; 1982; (11):1-25. PubMed ID: 12264851
[TBL] [Abstract][Full Text] [Related]
16. Anal dysplasia screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
[TBL] [Abstract][Full Text] [Related]
17. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
Bruni L; Albero G; Rowley J; Alemany L; Arbyn M; Giuliano AR; Markowitz LE; Broutet N; Taylor M
Lancet Glob Health; 2023 Sep; 11(9):e1345-e1362. PubMed ID: 37591583
[TBL] [Abstract][Full Text] [Related]
18. Role of Human Papillomavirus in Penile Carcinomas Worldwide.
Alemany L; Cubilla A; Halec G; Kasamatsu E; Quirós B; Masferrer E; Tous S; Lloveras B; Hernández-Suarez G; Lonsdale R; Tinoco L; Alejo M; Alvarado-Cabrero I; Laco J; Guimerà N; Poblet E; Lombardi LE; Bergeron C; Clavero O; Shin HR; Ferrera A; Felix A; Germar J; Mandys V; Clavel C; Tzardi M; Pons LE; Wain V; Cruz E; Molina C; Mota JD; Jach R; Velasco J; Carrilho C; López-Revilla R; Goodman MT; Quint WG; Castellsagué X; Bravo I; Pawlita M; Muñoz N; Bosch FX; de Sanjosé S;
Eur Urol; 2016 May; 69(5):953-61. PubMed ID: 26762611
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
20. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
